Skip to content

Clinical trials

Lung Diseases, Interstitial trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Country / region: South Korea Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20141
20161
20171
20192
20202
20224
20234
20244
20252
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting10
Completed7
Active, not recruiting5
Unknown status3
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim6
GlaxoSmithKline3
United Therapeutics3
Bristol-Myers Squibb2
Chung-Ang University Hospital2
Insmed Incorporated2
Kyntra Bio2
AstraZeneca1
Chonbuk National University1
Contineum Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial28
Idiopathic Pulmonary Fibrosis8
Pulmonary Fibrosis5
Hypertension, Pulmonary4
Scleroderma, Diffuse4
Connective Tissue Diseases3
Idiopathic Interstitial Pneumonias3
Arthritis, Rheumatoid2
Autoimmune Diseases2
Fibrosis2

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.